Pharmafile Logo
Pharmafocus logo
Advanced Search

Perrigo

Showing 14 posts of 14 posts found.

FDA advisory committee votes in favour of OTC contraceptive pill

May 11, 2023
Medical Communications Contraception, FDA, OTC, Perrigo, contraception

Perrigo Company has announced that the US Food and Drug Administration’s (FDA) Nonprescription Drugs Advisory Committee (NDAC) and the Obstetrics, …

News
neil_lister_perrigo

Perrigo name new head of its combined UK and Ireland business

April 26, 2016
Sales and Marketing Ireland, Perrigo, UK, lister, neil, new head

Perrigo has named Neil Lister as the head of its newly-combined UK and Ireland business. The manufacturer and distributor of …

Appointment
perrigo

Perrigo rejects $26 billion hostile Mylan takeover bid

November 13, 2015
Medical Communications, Sales and Marketing Mylan, Perrigo, mergers and acquisitions

Perrigo has rejected Mylan’s hostile $26 billion bid after a 60% majority of shareholders were unconvinced by the terms by …

News
Perrigo image

Perrigo buys OTC products from GSK

June 3, 2015
Sales and Marketing GSK, GlaxoSmithKline, Mylan, Perrigo, Teva, brett wells

In an all-cash move with no financial details disclosed Perrigo is buying a portfolio of leading over-the-counter products from GlaxoSmithKline. …

News
Teva image

Teva forges ahead with Mylan pursuit

May 6, 2015
Sales and Marketing Mylan, Perrigo, Teva, generics

Teva has reinforced its commitment to buy Mylan despite previous rejection and only days after Mylan upped its own bid …

News
Perrigo image

Perrigo bats away raised Mylan bid

April 30, 2015
Sales and Marketing Mylan, Perrigo, Teva, Vigodman, merger

Perrigo has rejected an updated $34.1 billion takeover bid from Mylan, whilst Teva has also written an open letter in …

News
teva_copy

M&A drama continues as Mylan rejects Teva

April 28, 2015
Sales and Marketing M&A, MA, Mylan, Perrigo, Teva, bids, generics, takeovers

Mylan has firmly rejected Teva’s acquisition bid, even though its own bid for Irish firm Perrigo has also been turned …

News
Teva image

Teva moves to buy Mylan

April 21, 2015
Research and Development, Sales and Marketing India, Mylan, Perrigo, Teva, US, Vigodman, generics, israel, merger

Israeli generics drug giant Teva has made an offer to buy its US rival Mylan for around $40.1 billion. The …

News
Perrigo image

Mylan in huge $29 billion bid for Perrigo

April 9, 2015
Abbott, Mylan, OTC, Perrigo, Shire

Mylan has offered to pay the over-the-counter (OTC) drug specialist Perrigo $28 billion to acquire its business. The proposed deal …

News
Perrigo image

Perrigo acquires Omega for $4.5 billion

November 7, 2014
Manufacturing and Production, Sales and Marketing Actavis, Boehringer Ingelheim, Boehringer Ingelheim., Elan, Perrigo, Sanofi, omega

In a deal worth $4.5 billion Perrigo has announced the acquisition of over-the-counter (OTC) drugmaker Omega. This places the Irish …

News
Elan image

Perrigo pays $8.6 billion for Elan

July 30, 2013
Research and Development, Sales and Marketing Elan, Perrigo, Tysabri

Generics firm Perrigo has snapped up Ireland-based Elan in a multi-billion dollar deal, ending a bitter takeover battle that has …

News
Perrigo image

Perrigo buys Rosemont for £180 million

February 12, 2013
Manufacturing and Production Perrigo, Rosemont

UK-based Rosemont Pharmaceuticals has been sold by its private equity owner to Perrigo of the US in a £180 million …

News

Pharma manufacturing news in brief

April 14, 2011
Manufacturing and Production Cangene, Chirotech, Grand River Aseptic Manufacturing, Perrigo, West Pharmaceutical Services

India’s Dr Reddy’s Laboratories has opened a new headquarters for its UK subsidiary ChiroTech, along with a new purpose-built laboratory …

News

Perrigo plans ‘massive transformation’ of API production

August 26, 2009
Manufacturing and Production India, Perrigo

Pharmaceutical manufacturer Perrigo has taken a majority stake in Vedants Drugs and Fine Chemicals in a move that will shift …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026